3.83 USD
0.000.00%
盘后 4.19 0.00%
2026-11-20
市值
$186.85M
市盈率
—
EPS
-2.80
股息率
—
52 周区间
2.96 – 14.53
成交量
1.19M
Beta
2.68
目标价
20.75
52W 低 2.9652W 高 14.53
价格走势
公司简介
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/mic...